It is time to stop ignoring malignancy in heart transplantation: A call to arms

被引：23
作者：
Hauptman, PJ
Mehra, MR
机构：
[1] St Louis Univ, Hlth Sci Ctr, St Louis, MO USA
[2] Alton Ochsner Med Fdn & Ochsner Clin, New Orleans, LA 70121 USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2005年 / 24卷 / 08期
关键词：
D O I：
10.1016/j.healun.2004.06.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Increasing numbers of patients are surviving more than 5 years after heart transplantation. Despite the dramatic nature of coronary allograft vasculopathy, Cardiac Transplant Research Database data have shown, and International Society for Heart and Lung Transplantation Registry data suggest, that malignancy is the leading cause of death among long-term survivors of heart transplantation. Recommendations on malignancy screening are provided as well as an outline of areas of ongoing uncertainty.
引用
收藏
页码：1111 / 1113
页数：3
相关论文
共 25 条
  • [1] Tacrolimus monotherapy in adult cardiac transplant recipients: Intermediate-term results
    Baran, DA
    Segura, L
    Kushwaha, S
    Courtney, M
    Correa, R
    Fallon, JT
    Cheng, J
    Lansman, SL
    Gass, AL
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (01) : 59 - 70
  • [2] Transmission of donor cancer into cardiothoracic transplant recipients
    Buell, JF
    Trofe, J
    Hanaway, MJ
    Lo, A
    Rosengard, B
    Rilo, H
    Alloway, R
    Beebe, T
    First, MR
    Woodle, ES
    [J]. SURGERY, 2001, 130 (04) : 660 - 666
  • [3] Czarnik BT, 2001, CIRCULATION, V104, P646
  • [4] Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients
    Eisen, HJ
    Tuzcu, EM
    Dorent, R
    Kobashigawa, J
    Mancini, D
    Valantine-von Kaeppler, HA
    Starling, RC
    Sorensen, K
    Hummel, M
    Lind, JM
    Abeywickrama, KH
    Bernhardt, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (09) : 847 - 858
  • [5] HAUPTMAN PJ, 1995, J HEART LUNG TRANSPL, V14, P654
  • [6] The Registry of the International Society for Heart and Lung Transplantation: Eighteenth official report-2001
    Hosenpud, JD
    Bennett, LE
    Keck, BM
    Boucek, MM
    Novick, RJ
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (08) : 805 - 815
  • [7] Myelodysplastic syndrome and acute myelogenous leukemia secondary to heart transplantation
    Huebner, G
    Karthaus, M
    Pethig, K
    Freund, M
    Ganser, A
    [J]. TRANSPLANTATION, 2000, 70 (04) : 688 - 690
  • [8] Evolving trends in risk profiles and causes of death after heart transplantation: A ten-year multi-institutional study
    Kirklin, JK
    Naftel, DC
    Bourge, RC
    McGiffin, DC
    Hill, JA
    Rodeheffer, RJ
    Jaski, BE
    Hauptman, PJ
    Weston, M
    White-Williams, C
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (04) : 881 - 890
  • [9] Kobashigawa J. K., 2004, Journal of Heart and Lung Transplantation, V23, pS51, DOI 10.1016/j.healun.2003.11.028
  • [10] EFFECT OF PRAVASTATIN ON OUTCOMES AFTER CARDIAC TRANSPLANTATION
    KOBASHIGAWA, JA
    KATZNELSON, S
    LAKS, H
    JOHNSON, JA
    YEATMAN, L
    WANG, XM
    CHIA, D
    TERASAKI, PI
    SABAD, A
    COGERT, GA
    TROSIAN, K
    HAMILTON, MA
    MORIGUCHI, JD
    KAWATA, N
    HAGE, A
    DRINKWATER, DC
    STEVENSON, LW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (10) : 621 - 627
123